相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Key factors in mTOR regulation
Xiaochun Bai et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
J. Wang et al.
ONCOGENE (2010)
LKB1 and AMP-activated protein kinase control of mTOR signalling and growth
R. J. Shaw
ACTA PHYSIOLOGICA (2009)
The coordination of nuclear and mitochondrial communication during aging and calorie restriction
Lydia W. S. Finley et al.
AGEING RESEARCH REVIEWS (2009)
Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase
Ron Grey et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells
Lisa S. Chen et al.
BLOOD (2009)
PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells
Fengxue Zhang et al.
CANCER BIOLOGY & THERAPY (2009)
Essential contribution of Ets-1 to constitutive Pim-3 expression in human pancreatic cancer cells
Ying-Yi Li et al.
CANCER SCIENCE (2009)
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Carles Canto et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
mTOR signaling at a glance
Mathieu Laplante et al.
JOURNAL OF CELL SCIENCE (2009)
Synthesis, Kinase Inhibitory Potencies, and in Vitro Antiproliferative Evaluation of New Pim Kinase Inhibitors
Rufine Akue-Gedu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases
Zuping Xia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Regulation of Bcl-2 Expression by HuR in HL60 Leukemia Cells and A431 Carcinoma Cells
Daniella Ishimaru et al.
MOLECULAR CANCER RESEARCH (2009)
Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells
Zanna Beharry et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Mammalian Target of Rapamycin: Discovery of Rapamycin Reveals a Signaling Pathway Important for Normal and Cancer Cell Growth
James J. Gibbons et al.
SEMINARS IN ONCOLOGY (2009)
Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases:: Chemistry, biological activities, and molecular modeling
Yunsong Tong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels
Daisuke Morishita et al.
CANCER RESEARCH (2008)
Potential roles for the PIM1 kinase in human cancer - A molecular and therapeutic appraisal
Nilesh Shah et al.
EUROPEAN JOURNAL OF CANCER (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
LKB1; linking cell structure and tumor suppression
A. F. Hezel et al.
ONCOGENE (2008)
Pim kinase-dependent inhibition of c-Myc degradation
Y. Zhang et al.
ONCOGENE (2008)
Global Regulation of Nucleotide Biosynthetic Genes by c-Myc
Yen-Chun Liu et al.
PLOS ONE (2008)
AMP-Activated Protein Kinase-Regulated Activation of the PGC-1α Promoter in Skeletal Muscle Cells
Isabella Irrcher et al.
PLOS ONE (2008)
PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation
Alessio Zippo et al.
NATURE CELL BIOLOGY (2007)
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Sibylle Jaeger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Structural analysis identifies imidazo[1,2-b]Pyridazines as PIM kinase inhibitors with In vitro antileukemic activity
Vanda Pogacic et al.
CANCER RESEARCH (2007)
Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis
Boryana Konstantinova Popivanova et al.
CANCER SCIENCE (2007)
Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates Bad to block Bad-mediated apoptosis in human pancreatic cancer cell lines
Ying-Yi Li et al.
CANCER RESEARCH (2006)
Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells
Eileen Connolly et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C
M Bachmann et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL
A Macdonald et al.
BMC CELL BIOLOGY (2006)
Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity
A Hahn-Windgassen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pim family kinases enhance tumor growth of prostate cancer cells
WW Chen et al.
MOLECULAR CANCER RESEARCH (2005)
Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis
F Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival
PS Hammerman et al.
BLOOD (2005)
Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle
Z Arany et al.
CELL METABOLISM (2005)
Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines
C Fujii et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors
H Mikkers et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles
M Suwa et al.
JOURNAL OF APPLIED PHYSIOLOGY (2003)
High-throughput retroviral tagging to identify components of specific signaling pathways in cancer
H Mikkers et al.
NATURE GENETICS (2002)
分享论文
